Literature DB >> 699677

In vitro comparison of the antifungal activities of R34,000, miconazole and amphotericin B.

D M Dixon, G E Wagner, S Shadomy, H J Shadomy.   

Abstract

In vitro susceptibilities of 78 isolates of pathogenic filamentous fungi to the imidazole compounds R34,000 and miconazole and to amphotericin B were determined using an agar dilution technique. Allescheria boydii, Sporothrix schenckii and the dematiaceous fungi (Cladosporium, Fonsecaea and Phialophora spp.) were most susceptible to miconazole with minimum inhibitory concentration (MIC) values ranging from less than or equal to 0.25 to 32 microgram/ml and with geometric mean MIC (G-MIC) values of 0.56-1.24 microgram/ml. Isolates of Aspergillus fumigatus were more susceptible to amphotericin B and miconazole than to R34,000 with G-MIC values of 1.20 and 3.48 microgram/ml, respectively. Coccidioides immitis, Histoplasma capsulatum and Blastomyces dermatitidis were highly susceptible to all three drugs (G-MICs greater than 1 microgram/ml); R34,000 was the most active of the three compounds against C. immitis (G-MIC = 0.44 microgram/ml).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 699677     DOI: 10.1159/000237809

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  3 in total

1.  In vitro studies with R 51,211 (itraconazole).

Authors:  A Espinel-Ingroff; S Shadomy; R J Gebhart
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

2.  Lyophilized microculture susceptibility test for ketoconazole, miconazole, clotrimazole, and griseofulvin against dermatophytes.

Authors:  T C Granade; M A Mothershead; W M Artis
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

Review 3.  Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections.

Authors:  R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-01       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.